Cures within reach

Cures Within Reach: Revolutionizing Healthcare through Repurposing Research

Cures Within Reach is a non-profit organization that is dedicated to improving patient quality and length of life by leveraging the speed, safety, and cost-effectiveness of repurposing research. The organization was founded in 2005 with the mission to identify and fund promising repurposing research projects that have the potential to make a significant impact on patient care.

Repurposing research involves finding new uses for existing drugs, devices, or therapies that have already been approved by regulatory agencies such as the FDA. This approach has several advantages over traditional drug development methods. First, it can significantly reduce the time and cost required to bring new treatments to market since much of the preclinical testing has already been done. Second, it can improve patient safety since these treatments have already undergone rigorous testing for their original indications. Finally, it can provide hope for patients who may not have other treatment options available.

Cures Within Reach works closely with researchers, clinicians, patients, and industry partners to identify promising repurposing opportunities across a wide range of therapeutic areas including cancer, rare diseases, neurological disorders, infectious diseases and more. The organization provides funding support through its CureAccelerator platform which connects researchers with philanthropic donors who are passionate about advancing healthcare innovation.

One example of Cures Within Reach's success is its partnership with Dr. David Flockhart at Indiana University School of Medicine who discovered that an existing drug used for treating alcoholism could also be effective in treating breast cancer patients whose tumors were resistant to standard chemotherapy regimens. With funding from Cures Within Reach's CureAccelerator platform Dr.Flockhart was able to conduct clinical trials which showed promising results leading him towards FDA approval.

Another example is CWR’s partnership with Drs.Timothy Kuzel & Michael Bishop at Rush University Medical Center in Chicago where they found an existing drug used for treating psoriasis could also be effective in treating a rare form of lymphoma. With funding from Cures Within Reach's CureAccelerator platform, Drs.Kuzel & Bishop were able to conduct clinical trials which showed promising results leading them towards FDA approval.

Cures Within Reach has also established partnerships with industry leaders such as Pfizer, AbbVie, and Takeda who recognize the value of repurposing research and are committed to advancing this approach. These partnerships have enabled Cures Within Reach to expand its reach and impact by providing additional resources and expertise.

In addition to funding research projects, Cures Within Reach is also committed to raising awareness about the potential of repurposing research through education and advocacy efforts. The organization hosts an annual conference that brings together researchers, clinicians, patients, industry partners and other stakeholders to share knowledge and best practices in repurposing research.

Overall,Cures Within Reach is a game-changer in healthcare innovation by leveraging the power of repurposing research for patient benefit. Its unique approach has already led to several successful treatments that have improved patient outcomes while reducing costs for both patients and healthcare systems. As the organization continues its mission it will undoubtedly continue making significant contributions towards improving patient care worldwide.